Global Bone Growth Stimulators Market

Bone Growth Stimulators Market Size, Share, Growth Analysis, By Product(Bone Growth Stimulation Devices {External Bone Growth Stimulators (Pulsed electromagnetic field devices, Combined magnetic field devices, Capacitive coupling devices), Ultrasonic Bone Growth Stimulators), By Application(Spinal Fusion Surgeries, Delayed Union & Non-Union Bone Fractures, Oral & Maxillofacial Surgeries, Others), By End User(Hospitals & Ambulatory Surgical Centers, Home Care Settings, Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2314 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 63 | Figures: 77

Bone Growth Stimulators Market Competitive Landscape

The competitive landscape for the bone growth stimulator industry contains information on each competitor. A business overview, financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, product launches, product breadth and depth, and application dominance are all included in the data.

Bone Growth Stimulators Market Top Player’s Company Profiles

  • Zimmer Biomet Holdings, Inc. (US) 
  • Stryker Corporation (US) 
  • Medtronic plc (Ireland) 
  • Orthofix Medical Inc. (US) 
  • Bioventus LLC (US) 
  • Arthrex, Inc. (US) 
  • Smith & Nephew plc (UK) 
  • Elizur Corporation (US) 
  • Isto Biologics (US) 
  • Ossatec Benelux B.V. (Netherlands) 
  • Terumo Corporation (Japan) 
  • Bioventus LLC (US) 
  • Ember Therapeutics (US) 
  • Isto Biologics (US) 
  • Ossatec Benelux B.V. (Netherlands) 
  • BONESUPPORT AB (Sweden) 
  • Regen Lab SA (Switzerland) 
  • Cerapedics, Inc. (US) 
  • Orthocell Ltd. (Australia) 
  • Alphatec Spine, Inc. (US) 
  • Bone Therapeutics SA (Belgium) 
  • EndoStim, Inc. (US)

Bone Growth Stimulators Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

The competitive landscape for the bone growth stimulator industry contains information on each competitor. A business overview, financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, product launches, product breadth and depth, and application dominance are all included in the data. 'Zimmer Biomet Holdings, Inc. (US) ', 'Stryker Corporation (US) ', 'Medtronic plc (Ireland) ', 'Orthofix Medical Inc. (US) ', 'Bioventus LLC (US) ', 'Arthrex, Inc. (US) ', 'Smith & Nephew plc (UK) ', 'Elizur Corporation (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'Terumo Corporation (Japan) ', 'Bioventus LLC (US) ', 'Ember Therapeutics (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'BONESUPPORT AB (Sweden) ', 'Regen Lab SA (Switzerland) ', 'Cerapedics, Inc. (US) ', 'Orthocell Ltd. (Australia) ', 'Alphatec Spine, Inc. (US) ', 'Bone Therapeutics SA (Belgium) ', 'EndoStim, Inc. (US)'

The rising prevalence of orthopedic conditions, such as fractures, delayed unions, non-unions, and osteoporosis-related fractures, is a significant driver for the bone growth stimulators market. As the aging population grows and the incidence of orthopedic conditions rises, the demand for bone growth stimulators increases.

In the present, the bone growth stimulators industry is being influenced by various consequential developments. A standout tendency is the increase in demand for treatments that are more amiable to patients and less invasive. In order to promote bone mending, bone growth stimulators are becoming a more popular choice for both healthcare providers and patients due to their ability to serve as a less intrusive alternative to conventional surgical means. This inclination is particularly noticeable when treating orthopedic ailments like spinal fusion, fractures, and others.

In 2022, North America had a predominant share of USD 0.72 billion. For bone growth stimulators, North America is the largest market. The market is expanding in North America due to the increased incidence of orthopedic injuries and disorders, the aging population, and the rising demand for less invasive procedures. The main elements promoting regional domination are the rising costs of healthcare, the prevalence of related bone illnesses, and the occurrences of these conditions that call for the administration of bone growth stimulators. The high shares of this region will also be strongly impacted by the robust procedure volumes related to orthopedic disorders.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Muscle Stimulator Market
Buy Now GET FREE SAMPLE
Bone Cement Market
Buy Now GET FREE SAMPLE
Bone Graft Substitutes Market
Buy Now GET FREE SAMPLE
Bone Replacement Market
Buy Now GET FREE SAMPLE
Human Growth Hormone Market
Buy Now GET FREE SAMPLE
Osseointegration Implants Market
Buy Now GET FREE SAMPLE
Dental Bone Graft Substitutes Market
Buy Now GET FREE SAMPLE
Osteoporosis Drugs Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Bone Growth Stimulators Market

Report ID: SQMIG35A2314

$5,300
BUY NOW GET FREE SAMPLE